Metformin in patients with hepatocellular carcinoma receiving immunotherapy

Affiliations

¹ Medical Data Analytics Centre, The Chinese University of Hong Kong, Hong Kong; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong.
² AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, Australia.
³ AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, Australia. Electronic address: ken.liu@health.nsw.gov.au.
⁴ Medical Data Analytics Centre, The Chinese University of Hong Kong, Hong Kong; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong. Electronic address: tcfyip@cuhk.edu.hk.

Comment

Huapeng Lin et al. J Hepatol. 2023 May.

. 2023 May;78(5):e180-e182.

doi: 10.1016/j.jhep.2022.12.011. Epub 2022 Dec 23.

¹ Medical Data Analytics Centre, The Chinese University of Hong Kong, Hong Kong; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong.
² AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, Australia.
³ AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, Australia. Electronic address: ken.liu@health.nsw.gov.au.
⁴ Medical Data Analytics Centre, The Chinese University of Hong Kong, Hong Kong; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong. Electronic address: tcfyip@cuhk.edu.hk.

No abstract available

Comment on

Metformin treatment rescues CD8⁺ T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD.
Wabitsch S, McCallen JD, Kamenyeva O, Ruf B, McVey JC, Kabat J, Walz JS, Rotman Y, Bauer KC, Craig AJ, Pouzolles M, Phadke I, Catania V, Green BL, Fu C, Diggs LP, Heinrich B, Wang XW, Ma C, Greten TF. Wabitsch S, et al. J Hepatol. 2022 Sep;77(3):748-760. doi: 10.1016/j.jhep.2022.03.010. Epub 2022 Apr 1. J Hepatol. 2022. PMID: 35378172 Free PMC article.